Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma.
de la Fuente MI, Touat M, van den Bent MJ, Preusser M, Peters KB, Young RJ, Huang RY, Ellingson BM, Capper D, Phillips JJ, Halasz LM, Shih HA, Rudà R, Lim-Fat MJ, Blumenthal DT, Weller M, Arakawa Y, Whittle JR, Ducray F, Reardon DA, Bi WL, Minniti G, Rahman R, Hervey-Jumper S, Chang SM, Wen PY. de la Fuente MI, et al. Among authors: ellingson bm. Neuro Oncol. 2024 Dec 25:noae259. doi: 10.1093/neuonc/noae259. Online ahead of print. Neuro Oncol. 2024. PMID: 39723472
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.
Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, de Groot J, Koh ES, Law I, Le Rhun E, Mair MJ, Minniti G, Rudà R, Scott AM, Short SC, Smits M, Suchorska B, Tolboom N, Traub-Weidinger T, Tonn JC, Verger A, Weller M, Wen PY, Preusser M. Albert NL, et al. Among authors: ellingson bm. Lancet Oncol. 2024 Jan;25(1):e29-e41. doi: 10.1016/S1470-2045(23)00525-9. Lancet Oncol. 2024. PMID: 38181810 Review.
A Hitchhiker's Guide Toward CSF Biomarkers for Neuro-Oncology.
Riviere-Cazaux C, Keough MB, Zuccato JA, Kumar R, Schulz S, Warrington AE, Ruff MW, Ellingson BM, Sanai N, Campian JL, Kizilbash SH, Parney IF, Zadeh G, Khasraw M, Kessler T, Sener U, Cahill DP, Mansouri A, Burns TC. Riviere-Cazaux C, et al. Among authors: ellingson bm. Neuro Oncol. 2024 Dec 30:noae276. doi: 10.1093/neuonc/noae276. Online ahead of print. Neuro Oncol. 2024. PMID: 39786477
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.
Sim HW, Wachsmuth L, Barnes EH, Yip S, Koh ES, Hall M, Jennens R, Ashley DM, Verhaak RG, Heimberger AB, Rosenthal MA, Hovey EJ, Ellingson BM, Tognela A, Gan HK, Wheeler H, Back M, McDonald KL, Long A, Cuff K, Begbie S, Gedye C, Mislang A, Le H, Johnson MO, Kong BY, Simes JR, Lwin Z, Khasraw M. Sim HW, et al. Among authors: ellingson bm. Neurooncol Adv. 2023 Sep 22;5(1):vdad124. doi: 10.1093/noajnl/vdad124. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37841696 Free PMC article.
TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial.
Everson RG, Hugo W, Sun L, Antonios J, Lee A, Ding L, Bu M, Khattab S, Chavez C, Billingslea-Yoon E, Salazar A, Ellingson BM, Cloughesy TF, Liau LM, Prins RM. Everson RG, et al. Among authors: ellingson bm. Nat Commun. 2024 May 8;15(1):3882. doi: 10.1038/s41467-024-48073-y. Nat Commun. 2024. PMID: 38719809 Free PMC article. Clinical Trial.
Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial.
Sarkaria JN, Ballman KV, Kizilbash SH, Sulman EP, Giannini C, Friday BB, Butowski NA, Mohile NA, Piccioni DE, Battiste JD, Drappatz J, Campian JL, Mashru S, Jaeckle KA, O'Brien BJ, Dixon JG, Kabat BF, Laack NL, Hu LS, Kaufmann T, Kumthekar P, Ellingson BM, Anderson SK, Galanis E. Sarkaria JN, et al. Among authors: ellingson bm. JAMA Oncol. 2024 Dec 1;10(12):1637-1644. doi: 10.1001/jamaoncol.2024.4361. JAMA Oncol. 2024. PMID: 39480453 Clinical Trial.
Reply.
Ellingson BM, Sanvito F, Pope WB, Cloughesy TF, Huang RY, Villanueva-Meyer JE, Barboriak DP, Shankar LK, Smits M, Kaufmann TJ, Boxerman JL, Weller M, Galanis E, Groot J, Chang SM, Gilbert MR, Lassman AB, Shiroishi MS, Nabavizadeh A, Mehta M, Stupp R, Wick W, Reardon DA, Wen PY, Vogelbaum MA, van den Bent M. Ellingson BM, et al. AJNR Am J Neuroradiol. 2025 Jan 8;46(1):221-222. doi: 10.3174/ajnr.A8621. AJNR Am J Neuroradiol. 2025. PMID: 39730160 No abstract available.
291 results